Oral Fosfomycin Formulation and Dosing for Uncomplicated UTI
Yes, oral fosfomycin is supplied as a white powder in a sachet that must be dissolved in water before ingestion, and the standard dose for uncomplicated urinary tract infection (acute cystitis) in women is a single 3-gram dose. 1
Formulation Details
Oral fosfomycin (fosfomycin tromethamine) is a white powder administered as a sachet, to be dissolved in water and then swallowed. 2 Each sachet contains 5.631 grams of fosfomycin tromethamine (equivalent to 3 grams of fosfomycin base), along with inactive ingredients including mandarin flavor, orange flavor, saccharin, and sucrose. 1
Critical Administration Points:
- Never take in dry form - must always be mixed with water before ingesting 1
- Can be taken with or without food 1
- Available in the United States and Europe 2
Dosing for Uncomplicated UTI
The recommended dosage for women 18 years and older with uncomplicated urinary tract infection (acute cystitis) is one sachet (3 grams) as a single dose. 1
Evidence Supporting Single-Dose Regimen:
The single 3-gram dose achieves:
- Peak urinary concentrations of 1053-4415 mg/L within 4 hours 3
- Urinary concentrations >128 mg/L (adequate to inhibit most uropathogens) maintained for 24-48 hours 3, 4
- Clinical cure rates of 83-91% 5
- Bacteriological eradication rates of 94.9% 6
Guideline Recommendations
Fosfomycin is recommended as a first-line agent for uncomplicated cystitis in women by multiple authoritative guidelines including IDSA, EAU, and NICE. 7, 5, 8, 3 The 2011 IDSA guidelines specifically state that fosfomycin trometamol (3 g in a single dose) is an appropriate choice for therapy due to minimal resistance and propensity for collateral damage, though it may have slightly inferior efficacy compared to standard short-course regimens. 7
Key Advantages:
- Narrow antimicrobial spectrum (primarily E. coli, S. saprophyticus) 5
- No collateral damage to microbiome 5
- Currently low resistance rates (<1% in E. coli) 8
- Excellent safety profile, including in pregnancy (Category B) 3
- Single-dose regimen ensures compliance 3
Important Limitations
Fosfomycin is NOT appropriate for complicated UTI, pyelonephritis, or bacteremia. 2, 1 The oral formulation does not achieve adequate levels in tissue or bloodstream for these conditions. 2 If treating pyelonephritis or suspected bacteremia, oral fosfomycin should not be used as it fails to reach therapeutic levels in renal parenchyma or blood. 2
The FDA label explicitly states fosfomycin is indicated only for uncomplicated UTI (acute cystitis) in women and is not indicated for pyelonephritis or perinephric abscess. 1